A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Providence Health & Services
OncoC4, Inc.
GlaxoSmithKline
Genmab
Seagen Inc.
Seagen Inc.
Pfizer
Alpha Tau Medical LTD.
Regeneron Pharmaceuticals
PDS Biotechnology Corp.
University of Colorado, Denver
Eastern Cooperative Oncology Group
H. Lee Moffitt Cancer Center and Research Institute
Pfizer
National Cancer Institute (NCI)
Amgen
Arcus Biosciences, Inc.
Washington University School of Medicine
Inhibrx Biosciences, Inc
Gustave Roussy, Cancer Campus, Grand Paris
Incyte Corporation
Erasca, Inc.
Canadian Cancer Trials Group
GlaxoSmithKline
Taiho Oncology, Inc.
Bayer
Mayo Clinic
M.D. Anderson Cancer Center
Fulgent Pharma LLC.
AstraZeneca
M.D. Anderson Cancer Center
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)
Gilead Sciences
R-Pharm
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Merus B.V.
Boehringer Ingelheim
Institute of Oncology Ljubljana
Memorial Sloan Kettering Cancer Center
Yonsei University
Ohio State University Comprehensive Cancer Center